NEW YORK – Quest Diagnostics said on Thursday that it has received US Food and Drug Administration Emergency Use Authorization for its Self-collection Kit for COVID-19.
The kit allows individuals to self-collect nasal SARS-CoV-2 test specimens either at home or a healthcare setting for testing with Quest's SARS-CoV-2 RT-PCR test, which received FDA EUA in mid-March.